Cardinal Health Inc has a consensus price target of $121.09 based on the ratings of 22 analysts. The high is $155 issued by B of A Securities on April 11, 2025. The low is $64 issued by Barclays on May 26, 2022. The 3 most-recent analyst ratings were released by B of A Securities, Mizuho, and Jefferies on April 11, 2025, March 31, 2025, and February 5, 2025, respectively. With an average price target of $151.67 between B of A Securities, Mizuho, and Jefferies, there's an implied 12.59% upside for Cardinal Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
04/11/2025 | Buy Now | 15.06% | B of A Securities | Michael Cherny79% | $150 → $155 | Maintains | Buy | Get Alert |
03/31/2025 | Buy Now | 11.35% | Mizuho | Steven Valiquette59% | $142 → $150 | Maintains | Outperform | Get Alert |
02/05/2025 | Buy Now | 11.35% | Jefferies | Brian Tanquilut45% | $140 → $150 | Upgrade | Hold → Buy | Get Alert |
02/04/2025 | Buy Now | 7.64% | JP Morgan | Lisa Gill60% | $142 → $145 | Maintains | Neutral | Get Alert |
02/04/2025 | Buy Now | 0.96% | Wells Fargo | Stephen Baxter58% | $135 → $136 | Maintains | Equal-Weight | Get Alert |
01/31/2025 | Buy Now | 5.41% | Morgan Stanley | Erin Wright76% | $136 → $142 | Maintains | Overweight | Get Alert |
01/29/2025 | Buy Now | 0.22% | Wells Fargo | Stephen Baxter58% | $127 → $135 | Maintains | Equal-Weight | Get Alert |
01/24/2025 | Buy Now | 5.41% | JP Morgan | Lisa Gill60% | $132 → $142 | Maintains | Neutral | Get Alert |
01/10/2025 | Buy Now | -4.24% | Citigroup | Daniel Grosslight44% | $120 → $129 | Maintains | Neutral | Get Alert |
01/08/2025 | Buy Now | 6.9% | TD Cowen | Charles Rhyee37% | $130 → $144 | Upgrade | Hold → Buy | Get Alert |
01/07/2025 | Buy Now | 3.93% | Evercore ISI Group | Elizabeth Anderson44% | $140 → $140 | Upgrade | In-Line → Outperform | Get Alert |
01/06/2025 | Buy Now | 7.64% | B of A Securities | Michael Cherny79% | $132 → $145 | Upgrade | Neutral → Buy | Get Alert |
12/17/2024 | Buy Now | 0.96% | Morgan Stanley | Erin Wright76% | $127 → $136 | Maintains | Overweight | Get Alert |
12/13/2024 | Buy Now | -5.72% | Wells Fargo | Stephen Baxter58% | $101 → $127 | Upgrade | Underweight → Equal-Weight | Get Alert |
11/04/2024 | Buy Now | -5.72% | Morgan Stanley | Erin Wright76% | $119 → $127 | Maintains | Overweight | Get Alert |
11/04/2024 | Buy Now | -7.95% | Deutsche Bank | George Hill63% | $119 → $124 | Maintains | Hold | Get Alert |
11/04/2024 | Buy Now | 3.18% | UBS | Kevin Caliendo73% | $134 → $139 | Maintains | Buy | Get Alert |
11/04/2024 | Buy Now | -10.92% | Mizuho | Ann Hynes86% | $110 → $120 | Maintains | Neutral | Get Alert |
11/04/2024 | Buy Now | -1.27% | Barclays | Stephanie Davis41% | $117 → $133 | Maintains | Overweight | Get Alert |
10/22/2024 | Buy Now | -0.53% | UBS | Kevin Caliendo73% | $125 → $134 | Maintains | Buy | Get Alert |
09/11/2024 | Buy Now | -7.21% | Argus Research | David Toung71% | $115 → $125 | Maintains | Buy | Get Alert |
08/21/2024 | Buy Now | -8.69% | JP Morgan | Lisa Gill60% | $111 → $123 | Maintains | Neutral | Get Alert |
08/16/2024 | Buy Now | -11.66% | Deutsche Bank | George Hill63% | $115 → $119 | Maintains | Hold | Get Alert |
08/15/2024 | Buy Now | -7.21% | UBS | Kevin Caliendo73% | $120 → $125 | Maintains | Buy | Get Alert |
08/15/2024 | Buy Now | -25.02% | Wells Fargo | Stephen Baxter58% | $95 → $101 | Maintains | Underweight | Get Alert |
08/15/2024 | Buy Now | -11.66% | Morgan Stanley | Erin Wright76% | $114 → $119 | Maintains | Overweight | Get Alert |
08/15/2024 | Buy Now | -14.63% | Evercore ISI Group | Elizabeth Anderson44% | $105 → $115 | Maintains | In-Line | Get Alert |
08/15/2024 | Buy Now | 1.7% | Baird | Eric Coldwell79% | $130 → $137 | Maintains | Outperform | Get Alert |
07/19/2024 | Buy Now | -20.57% | Citigroup | Daniel Grosslight44% | $115 → $107 | Maintains | Neutral | Get Alert |
07/09/2024 | Buy Now | -22.05% | Evercore ISI Group | Elizabeth Anderson44% | $115 → $105 | Maintains | In-Line | Get Alert |
07/09/2024 | Buy Now | -3.5% | Baird | Eric Coldwell79% | $129 → $130 | Maintains | Outperform | Get Alert |
05/15/2024 | Buy Now | -14.63% | Argus Research | David Toung71% | $120 → $115 | Maintains | Buy | Get Alert |
05/06/2024 | Buy Now | -18.34% | Deutsche Bank | George Hill63% | $116 → $110 | Maintains | Hold | Get Alert |
05/03/2024 | Buy Now | -14.63% | Evercore ISI Group | Elizabeth Anderson44% | $110 → $115 | Maintains | In-Line | Get Alert |
05/03/2024 | Buy Now | -4.98% | Baird | Eric Coldwell79% | $134 → $128 | Maintains | Outperform | Get Alert |
04/29/2024 | Buy Now | -30.22% | Wells Fargo | Stephen Baxter58% | $96 → $94 | Maintains | Underweight | Get Alert |
02/26/2024 | Buy Now | -7.21% | Leerink Partners | Michael Cherny79% | → $125 | Initiates | → Outperform | Get Alert |
02/09/2024 | Buy Now | — | Argus Research | David Toung71% | — | Upgrade | Hold → Buy | Get Alert |
02/05/2024 | Buy Now | -7.21% | UBS | Kevin Caliendo73% | $122 → $125 | Maintains | Buy | Get Alert |
01/29/2024 | Buy Now | -9.44% | UBS | Kevin Caliendo73% | $114 → $122 | Maintains | Buy | Get Alert |
01/03/2024 | Buy Now | -13.15% | Barclays | Stephanie Davis41% | → $117 | Initiates | → Overweight | Get Alert |
12/14/2023 | Buy Now | -28.74% | Wells Fargo | Stephen Baxter58% | → $96 | Initiates | → Underweight | Get Alert |
11/17/2023 | Buy Now | -16.86% | JP Morgan | Lisa Gill60% | $101 → $112 | Maintains | Neutral | Get Alert |
11/09/2023 | Buy Now | -22.05% | Deutsche Bank | George Hill63% | $102 → $105 | Maintains | Hold | Get Alert |
11/06/2023 | Buy Now | -22.8% | Mizuho | Ann Hynes86% | $95 → $104 | Maintains | Neutral | Get Alert |
08/17/2023 | Buy Now | -24.28% | Deutsche Bank | George Hill63% | $90 → $102 | Maintains | Hold | Get Alert |
08/16/2023 | Buy Now | -33.19% | TD Cowen | Charles Rhyee37% | $88 → $90 | Maintains | Market Perform | Get Alert |
08/16/2023 | Buy Now | -25.02% | JP Morgan | Lisa Gill60% | $93 → $101 | Maintains | Neutral | Get Alert |
08/16/2023 | Buy Now | -25.77% | Morgan Stanley | Erin Wright76% | $92 → $100 | Maintains | Overweight | Get Alert |
08/16/2023 | Buy Now | -19.83% | Baird | Eric Coldwell79% | $107 → $108 | Maintains | Outperform | Get Alert |
08/16/2023 | Buy Now | -28.74% | Mizuho | Ann Hynes86% | $94 → $96 | Maintains | Neutral | Get Alert |
07/11/2023 | Buy Now | -30.22% | Mizuho | Ann Hynes86% | $85 → $94 | Maintains | Neutral | Get Alert |
07/10/2023 | Buy Now | -25.77% | Evercore ISI Group | Elizabeth Anderson44% | → $100 | Downgrade | Outperform → In-Line | Get Alert |
06/12/2023 | Buy Now | -33.19% | Citigroup | Daniel Grosslight44% | $88 → $90 | Maintains | Neutral | Get Alert |
06/12/2023 | Buy Now | -36.9% | Barclays | Steven Valiquette58% | $80 → $85 | Maintains | Equal-Weight | Get Alert |
06/12/2023 | Buy Now | -25.77% | Credit Suisse | Jonathan Yong65% | $90 → $100 | Maintains | Neutral | Get Alert |
06/12/2023 | Buy Now | -27.99% | UBS | Kevin Caliendo73% | $93 → $97 | Maintains | Buy | Get Alert |
06/09/2023 | Buy Now | -30.96% | JP Morgan | Lisa Gill60% | $90 → $93 | Maintains | Neutral | Get Alert |
05/08/2023 | Buy Now | -34.67% | Citigroup | Daniel Grosslight44% | $77 → $88 | Maintains | Neutral | Get Alert |
05/08/2023 | Buy Now | -33.19% | Deutsche Bank | George Hill63% | $88 → $90 | Maintains | Hold | Get Alert |
05/05/2023 | Buy Now | -34.67% | Barclays | Steven Valiquette58% | $77 → $88 | Maintains | Equal-Weight | Get Alert |
04/26/2023 | Buy Now | -34.67% | Deutsche Bank | George Hill63% | $77 → $88 | Maintains | Hold | Get Alert |
03/31/2023 | Buy Now | -42.84% | Citigroup | Daniel Grosslight44% | → $77 | Initiates | → Neutral | Get Alert |
03/22/2023 | Buy Now | -42.84% | Deutsche Bank | George Hill63% | $82 → $77 | Maintains | Hold | Get Alert |
02/03/2023 | Buy Now | -31.71% | Credit Suisse | Jonathan Yong65% | $89 → $92 | Maintains | Neutral | Get Alert |
02/03/2023 | Buy Now | -33.19% | Morgan Stanley | Erin Wright76% | $86 → $90 | Maintains | Overweight | Get Alert |
02/03/2023 | Buy Now | -30.22% | Baird | Eric Coldwell79% | $87 → $94 | Upgrade | Neutral → Outperform | Get Alert |
01/31/2023 | Buy Now | -32.45% | UBS | Kevin Caliendo73% | $78 → $91 | Maintains | Buy | Get Alert |
01/06/2023 | Buy Now | -36.16% | Morgan Stanley | Erin Wright76% | $82 → $86 | Maintains | Overweight | Get Alert |
11/22/2022 | Buy Now | -41.36% | Credit Suisse | A.J. Rice70% | $64 → $79 | Maintains | Neutral | Get Alert |
11/14/2022 | Buy Now | -45.07% | Mizuho | Ann Hynes86% | $66 → $74 | Maintains | Neutral | Get Alert |
11/07/2022 | Buy Now | -39.13% | Morgan Stanley | Erin Wright76% | $76 → $82 | Maintains | Overweight | Get Alert |
11/07/2022 | Buy Now | -39.13% | Baird | Eric Coldwell79% | $74 → $82 | Maintains | Neutral | Get Alert |
11/04/2022 | Buy Now | -40.61% | B of A Securities | Michael Cherny79% | $64 → $80 | Upgrade | Underperform → Neutral | Get Alert |
08/29/2022 | Buy Now | -42.1% | UBS | Kevin Caliendo73% | $61 → $78 | Maintains | Buy | Get Alert |
08/22/2022 | Buy Now | -43.58% | Morgan Stanley | Erin Wright76% | $70 → $76 | Maintains | Overweight | Get Alert |
08/16/2022 | Buy Now | -46.55% | Cowen & Co. | Charles Ryhee52% | $59 → $72 | Maintains | Market Perform | Get Alert |
08/12/2022 | Buy Now | -52.49% | Credit Suisse | A.J. Rice70% | $56 → $64 | Maintains | Neutral | Get Alert |
08/12/2022 | Buy Now | -45.81% | Baird | Eric Coldwell79% | $57 → $73 | Maintains | Neutral | Get Alert |
07/14/2022 | Buy Now | -48.04% | Morgan Stanley | Ricky Goldwasser80% | $74 → $70 | Maintains | Overweight | Get Alert |
05/26/2022 | Buy Now | -52.49% | Barclays | Steve Valiquette54% | $70 → $64 | Downgrade | Overweight → Equal-Weight | Get Alert |
05/18/2022 | Buy Now | -49.52% | Evercore ISI Group | Elizabeth Anderson44% | → $68 | Upgrade | In-Line → Outperform | Get Alert |
05/06/2022 | Buy Now | -58.43% | Credit Suisse | A.J. Rice70% | $58 → $56 | Maintains | Neutral | Get Alert |
The latest price target for Cardinal Health (NYSE:CAH) was reported by B of A Securities on April 11, 2025. The analyst firm set a price target for $155.00 expecting CAH to rise to within 12 months (a possible 15.06% upside). 36 analyst firms have reported ratings in the last year.
The latest analyst rating for Cardinal Health (NYSE:CAH) was provided by B of A Securities, and Cardinal Health maintained their buy rating.
The last upgrade for Cardinal Health Inc happened on February 5, 2025 when Jefferies raised their price target to $150. Jefferies previously had a hold for Cardinal Health Inc.
The last downgrade for Cardinal Health Inc happened on July 10, 2023 when Evercore ISI Group changed their price target from N/A to $100 for Cardinal Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cardinal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cardinal Health was filed on April 11, 2025 so you should expect the next rating to be made available sometime around April 11, 2026.
While ratings are subjective and will change, the latest Cardinal Health (CAH) rating was a maintained with a price target of $150.00 to $155.00. The current price Cardinal Health (CAH) is trading at is $134.71, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.